Stocks sink on new COVID variant; Dow loses 905 points - Los Angeles Times
Advertisement

Stocks sink on new COVID variant; Dow loses 905 points

A detail view of the pediment above the entrance of the New York Stock Exchange.
Investors weighed news about a new COVID-19 variant that could reverse progress at getting the pandemic under control.
(John Minchillo / Associated Press)
Share via

Stocks sank Friday, with the Dow Jones industrial average briefly falling more than 1,000 points, as a new coronavirus variant first detected in South Africa appeared to be spreading across the globe.

Investors were uncertain whether the variant could potentially reverse months of progress at getting the COVID-19 pandemic under control.

The Standard & Poor’s 500 index dropped 106.84 points, or 2.3%, to close at 4,594.62. It was the worst day for Wall Street’s benchmark index since February.

Advertisement

The index was dragged lower by companies in the banking, travel, energy and other sectors as investors tried to reposition to protect themselves financially from the new variant. The World Health Organization called the variant “highly transmissible.â€

The supply-chain crisis and COVID fears seemed to hold shoppers back, as Black Friday 2021 came and went without major discounts or huge crowds.

The price of oil fell about 13%, the biggest decline since early in the pandemic, amid worries of another slowdown in the global economy. That in turn dragged down energy stocks. Exxon Mobil shares fell 3.5% while Chevron fell 2.3%.

The blue chips closed down 905.04 points to end the day at 34,899.34. The Nasdaq composite index lost 353.57 points, or 2.2%, ending at 15,491.66.

Advertisement

“Investors are likely to shoot first and ask questions later until more is known,†Jeffrey Halley of Oanda said in a report. That was evident from the action in the bond market, where the yield on the 10-year Treasury note fell to 1.48% from 1.64% on Wednesday. As a result, banks took some of the heaviest losses. JPMorgan Chase dropped 3%.

There have been other variants of the coronavirus — the Delta variant devastated much of the U.S. throughout the summer — and investors, public officials and the general public are jittery about any new variant that’s spreading. It’s been nearly two years since COVID-19 emerged, killing more than 5 million people around the globe so far.

Cases of the new variant have been detected in Hong Kong, Belgium and Tel Aviv as well as major South African cities such as Johannesburg.

Advertisement

The economic effects of this variant are already being felt. Flights between South Africa and Europe were being subject to quarantine or shut down altogether, and the White House said the U.S. will restrict travel from eight African countries beginning Monday. Airline stocks were quickly sold off, with United Airlines dropping 9.6% and American Airlines falling 8.8%.

“COVID had seemingly been put in the rearview mirror by financial markets until recently,†said Douglas Porter, chief economist at BMO Capital Markets. “At the least, [the virus] is likely to continue throwing sand in the gears of the global economy in 2022, restraining the recovery [and] keeping kinks in the supply chain.â€

The logjam at the ports and larger supply chain disruptions have led to record-setting profits for big companies in the logistics business.

Bitcoin also got caught up in the selling. The digital currency dropped 8.4% to $54,179, according to CoinDesk.

One sign of Wall Street’s anxiety was the VIX, the market’s measurement of volatility that is sometimes referred to as its “fear gauge.†The VIX jumped 53.6% to a reading of 28.54, its highest reading since January before the vaccines began to be widely distributed.

Fearful of more lockdowns and travel bans, investors moved money into companies that largely benefited from previous waves, such as Zoom Communications for meetings and Peloton for at-home exercise equipment. Shares in both companies rose nearly 6%.

The COVID-19 vaccine manufacturers were among the biggest beneficiaries of the emergence of the new variant and the subsequent investor reaction. Pfizer shares rose more than 6%; Moderna shares jumped more than 20%.

Advertisement

Merck shares fell 3.8%, however. Although U.S. health officials said Merck’s experimental treatment for COVID-19 was effective, data showed the pill was not as good at keeping patients out of the hospital as originally thought.

Investors are worried that the supply chain issues that have dragged down global markets for months will worsen. Ports and freight yards are vulnerable and could be shut by new, localized outbreaks.

From canned staples to full Thanksgiving dinners, L.A. food banks and community centers help households feeling the pinch of higher prices this year.

“Supply chains are already stretched,†said Neil Shearing, an economist with Capital Economics in London. “A new, more dangerous virus wave could cause some workers to temporarily exit the workforce and deter others from returning, making current labor shortages worse.â€

The variant also puts more pressure on central banks that are already faced with a dilemma: whether and when to raise interest rates to combat rising inflation. “The threat of a new, more serious variant of the virus may be a reason for central banks to postpone plans to raise interest rates until the picture becomes clearer,†Shearing said.

The Friday after Thanksgiving is typically the slowest stock-trading day of the year, with the market closing at 1 p.m. Eastern time. However, volume on Friday was much higher than it would typically be for a holiday-shortened day. About 3.4 billion shares changed hands on the New York Stock Exchange, which is only modestly less than the 4 billion shares traded on an average day.

Advertisement